LH - Laboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript
2024-04-25 15:55:26 ET
Start Time: 09:00
End Time: 10:01
Laboratory Corporation of America Holdings (LH)
Q1 2024 Earnings Conference Call
April 25, 2024, 09:00 AM ET
Company Participants
Adam Schechter - Chairman, President and CEO
Glenn Eisenberg - EVP and CFO
Christin O’Donnell - VP of IR
Conference Call Participants
Jack Meehan - Nephron Research
Erin Wright - Morgan Stanley
Patrick Donnelly - Citi
Michael Cherny - Leerink Partners
Ann Hynes - Mizuho Securities
Elizabeth Anderson - Evercore ISI
Kevin Caliendo - UBS
Andrew Brackmann - William Blair
Eric Coldwell - Baird
Michael Ryskin - Bank of America
Brian Tanquilut - Jefferies
Pito Chickering - Deutsche Bank
Kieran Ryan - Deutsche Bank
Stephanie Davis - Barclays
Presentation
Operator
Good day and thank you for standing by. Welcome to the Laboratory Corporation of America Holdings First Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, Christin O’Donnell, Vice President, Investor Relations. Please go ahead.
Christin O’Donnell
Thank you, operator. Good morning, and welcome to Labcorp’s first quarter 2024 conference call. As detailed in today’s press release, there will be a replay of this conference call available via telephone and Internet. With me today are Adam Schechter, Chairman and Chief Executive Officer; and Glenn Eisenberg, Executive Vice President and Chief Financial Officer.
This morning, in the Investor Relations section of our website at www. Labcorp.com, we posted both our press release and an Investor Relations presentation with additional information on our business operations, which include a reconciliation of the non-GAAP financial measures to the most comparable GAAP financial measures, both of which are discussed during today’s call.
Additionally, we are making forward-looking statements. These forward-looking statements include, but are not limited to, statements with respect to the estimated 2024 guidance and the related assumptions, the recently completed spin-off of Fortrea Holdings Inc., the impact of various factors on the company’s businesses, operating and financial results, cash flows and/or financial condition, including the COVID-19 pandemic and global economic and market conditions; future business strategies, expected savings, benefits and synergies from the LaunchPad initiatives and from other acquisitions and other strategic transactions and partnerships and opportunities for future growth. Each of the forward-looking statements is subject to change based upon various factors, many of which are beyond our control.
More information is included in our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q and in the company’s other filings with the SEC. We have no obligation to provide any updates to these forward-looking statements, even if our expectations change....
Laboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript